Florindo d’Onofrio

Post-traumatic headaches: an epidemiological overview

A. Tessitore, G. Tedeschi, A. Russo, 2014, Neurological Sciences.

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

F. Vernieri, C. Altamura, P. Barbanti, 2024, Journal of neurology.

Headache, eating and sleeping behaviors and lifestyle factors in preadolescents and adolescents: preliminary results from an Italian population study

G. Casucci, G. Bussone, L. Grazzi, 2012, Neurological Sciences.

Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.

L. Borrello, A. Doretti, G. Egeo, 2024, Neurology and therapy.

Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study

P. Barbanti, G. Egeo, C. Aurilia, 2024, Journal of neurology.

Migraine and movement disorders

C. Mundi, A. Mazzeo, P. Barbanti, 2012, Neurological Sciences.